Table 2.
Distribution of PHQ-9, GAD-7, ISS, and PCL-C scores at baseline and at long-term follow-up.
| Baseline | Follow-up | |
|---|---|---|
| Patient Health Questionnaire-9 (PHQ-9) | ||
| Minimal (0–4) | 37/52 (71.2 %) | 34/52 (65.4 %) |
| Mild (5–9) | 7/52 (13.5 %) | 10/52 (19.2 %) |
| Moderate (10–14) | 7/52 (13.5 %) | 8/52 (15.4 %) |
| Severe (≥15) | 1/52 (1.9 %) | 0 |
| Threshold (≥10) | 8/52 (15.4 %) | 8/52 (15.4 %) |
| Generalized Anxiety Disorder-7 (GAD-7) | ||
| Minimal (0–4) | 36/51 (70.6 %) | 36/51 (70.6 %) |
| Mild (5–9) | 13/51 (25.5 %) | 15/51 (29.4 %) |
| Moderate (10–14) | 2/51 (3.9 %) | 0 |
| Severe (≥15) | 0 | 0 |
| Threshold (≥10) | 2/51 (3.9 %) | 0 |
| Insomnia Severity Scale (ISS) | ||
| Minimal (0–7) | 30/52 (57.7 %) | 33/52 (63.5 %) |
| Mild (8–14) | 15/52 (28.8 %) | 10/52 (19.2 %) |
| Moderate (15–21) | 3/52 (5.8 %) | 6/52 (11.5 %) |
| Severe (≥22) | 4/52 (7.7 %) | 3/52 (5.8 %) |
| Threshold (≥10) | 13/52 (25.0 %) | 17/52 (32.7 %) |
| PTSD Checklist-Civilian (PCL-C) | ||
| Minimal (<30) | 40/50 (80.0 %) | 35/50 (70.0 %) |
| Mild (30–39) | 7/50 (14.0 %) | 9/50 (18.0 %) |
| Moderate (40–49) | 1/50 (2.0 %) | 1/50 (2.0 %) |
| Severe (≥50) | 2/50 (4.0 %) | 0 |
| Threshold (≥35) | 6/50 (12.0 %) | 11/50 (22.0 %) |